Studies involving the NHS in England
The National Institute for Health Research (NIHR) Clinical Research Network (CRN) offers a range of services across the research pathway that will help study feasibility, set up and delivery to time and target.
These services are available to any study that is eligible or applying for CRN support and which involves the NHS in England. This service is available to both commercial and non-commercial sponsored studies regardless of location, study type, study size or therapy area of the research. Visit the NIHR CRN Study Support Service for more information.
To apply for NIHR Clinical Research Network (CRN) support and inclusion in the NIHR CRN Portfolio, you should indicate this in the relevant questions on the IRAS Project Filter page. Information from your IRAS Form will then automatically be shared with the NIHR CRN upon submission, and used to determine whether your study is eligible for NIHR CRN support and inclusion on the NIHR CRN Portfolio. The NIHR CRN will notify you of their decision by email.
Seeking advice and support
Toolkits and Decision Tools
The Integrated Research Application System (IRAS) contains a wealth of guidance and links to help you complete your applications. This guidance is provided within the data sets, through clicking the question specific guidance buttons (green i buttons) and through the help section. If you are unclear about the application or review process for a particular review body, please contact them for advice, as this could save you delays in addressing issues later in the review process.
You are strongly advised to contact the lead NHS research and development office for advice on setting up your study.
If you are running your study through the clinical research networks you should contact the relevant network as early as possible to seek advice on the support available and get up to date news on how to run your project efficiently in the UK.
- Clinical Trials Toolkit : Guides you through the requirements when testing the safety or efficacy of a medicinal product.
- Experimental Medicine Toolkit : For a range of interventional research types.
- Regulatory Advice Service for Regenerative Medicine: single point of access to multi-agency advice service.